NO20042497L - 4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse - Google Patents

4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse

Info

Publication number
NO20042497L
NO20042497L NO20042497A NO20042497A NO20042497L NO 20042497 L NO20042497 L NO 20042497L NO 20042497 A NO20042497 A NO 20042497A NO 20042497 A NO20042497 A NO 20042497A NO 20042497 L NO20042497 L NO 20042497L
Authority
NO
Norway
Prior art keywords
difluoro
tetrahydro
salts
benzazepine derivatives
benzazepine
Prior art date
Application number
NO20042497A
Other languages
English (en)
Norwegian (no)
Inventor
Hiroyuki Koshio
Seijiro Akamatsu
Issei Tsukamoto
Takahiro Kuramochi
Chikashi Saitoh
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO20042497L publication Critical patent/NO20042497L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
NO20042497A 2001-11-16 2004-06-15 4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse NO20042497L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001350909 2001-11-16
JP2002252931 2002-08-30
PCT/JP2002/011842 WO2003042181A1 (fr) 2001-11-16 2002-11-13 Derives de 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine, ou sels desdits derives

Publications (1)

Publication Number Publication Date
NO20042497L true NO20042497L (no) 2004-07-21

Family

ID=26624548

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042497A NO20042497L (no) 2001-11-16 2004-06-15 4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse

Country Status (17)

Country Link
US (1) US7169772B2 (ja)
EP (1) EP1445253B1 (ja)
JP (1) JP4075064B2 (ja)
KR (1) KR100632882B1 (ja)
CN (1) CN1323076C (ja)
AT (1) ATE438626T1 (ja)
AU (1) AU2002349773B2 (ja)
BR (1) BR0214224A (ja)
CA (1) CA2464069A1 (ja)
DE (1) DE60233251D1 (ja)
ES (1) ES2327620T3 (ja)
HU (1) HUP0402235A2 (ja)
MX (1) MXPA04004501A (ja)
NO (1) NO20042497L (ja)
PL (1) PL369999A1 (ja)
RU (1) RU2268882C1 (ja)
WO (1) WO2003042181A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2004027378A2 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
US7241803B2 (en) * 2002-11-21 2007-07-10 New York Blood Center Compounds for inhibition of HIV infection by blocking HIV entry
SI1619185T1 (sl) * 2003-04-28 2011-09-30 Astellas Pharma Inc 4,4-difluoro-1,2,3,4-tetrahidro-5H-1-benzazepinski derivat ali njegova sol
WO2005090282A1 (en) 2004-03-12 2005-09-29 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
EP2778234B1 (en) 2005-05-31 2017-09-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
EP1935986B1 (en) 2005-05-31 2014-04-16 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
WO2007010383A1 (ja) * 2005-07-22 2007-01-25 Mochida Pharmaceutical Co., Ltd. 新規なヘテロシクリデンアセトアミド誘導体
JP5164510B2 (ja) * 2006-10-06 2013-03-21 日本曹達株式会社 含窒素複素環化合物および有害生物防除剤
EP2119719A1 (en) 2006-12-26 2009-11-18 Daiichi Sankyo Company, Limited Thiazepine derivative
PE20081692A1 (es) 2007-01-24 2008-12-18 Mochida Pharm Co Ltd Nuevo derivado de heterocicliden acetamida
US20100016285A1 (en) * 2007-01-24 2010-01-21 Mochida Pharmaceutical Co., Ltd. Heterocyclidene-n-(aryl) acetamide derivative
CN101679244B (zh) 2007-04-11 2014-01-01 橘生药品工业株式会社 5元杂环衍生物及其医药用途
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
PT3085381T (pt) * 2008-05-21 2018-05-18 Ferring Bv Desmopressina orodispersível para aumentar o período inicial de sono não perturbado pela noctúria
UY32940A (es) 2009-10-27 2011-05-31 Bayer Cropscience Ag Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
RS56804B1 (sr) 2012-06-11 2018-04-30 Tacurion Postupak za proizvodnju jedinjenja 4,4,7-trifluoro-1,2,3,4-tetrahidro-5h-1-benzazepina i intermedijer za njegovu sintezu
US9586905B2 (en) * 2012-12-26 2017-03-07 Sanwa Kagaku Kenkyusho Co., Ltd. Benzoazepine derivative and medical use thereof
WO2015116867A1 (en) 2014-01-29 2015-08-06 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
CN105310978A (zh) * 2014-08-04 2016-02-10 李峰 一种含有活性成分盐酸考尼伐坦的药物组合物及其制剂
CN112079826B (zh) * 2020-09-17 2022-07-29 广州中医药大学(广州中医药研究院) 一类甾体合成酶抑制剂及其治疗应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1039999A (zh) * 1988-07-30 1990-02-28 刘晓非 多层复合装饰板及制作方法
TW270927B (ja) 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
PL182011B1 (en) 1993-08-26 2001-10-31 Yamanouchi Pharma Co Ltd Benzazepine derivative, pharmaceutic composition and intermediate compounds
TW359669B (en) * 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives
JPH09221475A (ja) 1996-02-13 1997-08-26 Yamanouchi Pharmaceut Co Ltd 新規なオキシム誘導体
AR011913A1 (es) 1997-03-06 2000-09-13 Yamano Masaki Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.

Also Published As

Publication number Publication date
EP1445253B1 (en) 2009-08-05
CA2464069A1 (en) 2003-05-22
ATE438626T1 (de) 2009-08-15
US20050004103A1 (en) 2005-01-06
KR100632882B1 (ko) 2006-10-13
CN1585752A (zh) 2005-02-23
DE60233251D1 (de) 2009-09-17
JP4075064B2 (ja) 2008-04-16
RU2268882C1 (ru) 2006-01-27
PL369999A1 (en) 2005-05-16
EP1445253A1 (en) 2004-08-11
BR0214224A (pt) 2004-09-21
EP1445253A4 (en) 2005-11-16
KR20050044401A (ko) 2005-05-12
HUP0402235A2 (hu) 2005-02-28
ES2327620T3 (es) 2009-11-02
CN1323076C (zh) 2007-06-27
MXPA04004501A (es) 2004-08-11
WO2003042181A1 (fr) 2003-05-22
RU2004118063A (ru) 2006-01-10
JPWO2003042181A1 (ja) 2005-03-10
AU2002349773B2 (en) 2007-12-13
US7169772B2 (en) 2007-01-30

Similar Documents

Publication Publication Date Title
NO20042497L (no) 4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse
MXPA04002382A (es) Combinaciones de herbicidas y antidotos.
ITTO20011228A0 (it) Contenitore per ago monouso.
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
TW200738629A (en) Ethylenediamine derivatives
RS50814B (sr) Tartaratne soli 5,8,14-triazatetraciklo(10.3.1.02,11.04,9)- heksadeka-2(11),3,5,7,9-pentaena
ATE410165T1 (de) Nociceptin-analoga
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
PT1191025E (pt) Cristais de lansoprazol
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
SE0101932D0 (sv) Pharmaceutical combinations
ATE236657T1 (de) Konjugat, umfassend einen folsäureantagonisten und einen träger
NO20055602L (no) 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepin-derivat og salt derav
HRP20050075A2 (en) Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
ATE250021T1 (de) Hydroxycyclopentanone
ITGE20020050A1 (it) Procedimento per il trattamento di filati mediante agugliatura.
HUP9904030A2 (hu) Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására
HRP20040186B1 (en) Use of lhrh-antagonists for the improvement of t-cell mediated immunity
ATE248168T1 (de) Racemisierung von r,s-dioxo- benzylpyrrolopiperidin
GR3031162T3 (en) Thiazolotriazole and thiazolodiazole derivatives with fungicidal activity.
YU83903A (sh) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
ATE212504T1 (de) Organische peroxoverbindungen enthaltendes mittel zur instrumentendesinfektion
NO20041878D0 (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
RS47804A (en) 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof